Page last updated: 2024-10-22

amsacrine and Myeloproliferative Disorders

amsacrine has been researched along with Myeloproliferative Disorders in 1 studies

Amsacrine: An aminoacridine derivative that intercalates into DNA and is used as an antineoplastic agent.
amsacrine : A sulfonamide that is N-phenylmethanesulfonamide substituted by a methoxy group at position 3 and an acridin-9-ylamino group at position 4. It exhibits antineoplastic activity.

Myeloproliferative Disorders: Conditions which cause proliferation of hemopoietically active tissue or of tissue which has embryonic hemopoietic potential. They all involve dysregulation of multipotent MYELOID PROGENITOR CELLS, most often caused by a mutation in the JAK2 PROTEIN TYROSINE KINASE.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mahal, PS1
Legha, SS1
Valdivieso, M1
Luna, M1
Benjamin, RS1
Bodey, GP1

Other Studies

1 other study available for amsacrine and Myeloproliferative Disorders

ArticleYear
AMSA toxicity in patients with abnormal liver function.
    European journal of cancer & clinical oncology, 1981, Volume: 17, Issue:12

    Topics: Adult; Aged; Aminoacridines; Amsacrine; Antineoplastic Agents; Dose-Response Relationship, Drug; Hum

1981